Newsletter | July 27, 2019

07.27.19 -- New Technology Targets Cancer, Other Diseases, In Relapse Patients

 
Industry Insights
Choosing The Best Sterile Dosage Form For Your Phase 1 Needs
White Paper | By Tony Pidgeon, Thermo Fisher Scientific

When developing a parenteral product, pharmaceutical scientists are faced with a variety of choices — choices that can be conflicting or present differing advantages.

Viral Clearance: The Basics On How To Conduct Effective Studies
White Paper | GE Healthcare Life Sciences

Effective viral clearance studies remain one of the challenges facing manufacturers of biologics. These studies are an essential part of process validation and are critical to ensure drug safety. This article provides the basics of what you need to know when studying virus reduction of a chromatography step.

Alzheimer’s Disease: A Smoking Gun With No Suspect
Article | Bio-Rad Laboratories, Inc.

Despite such a clear link between AD and the buildup of beta-amyloid plaques, researchers and drug companies have not been successful in developing an effective therapy that targets beta-amyloid. Fortunately, there are several studies targeting beta-amyloid.

Most Popular News
Solutions
Chemical Inventory Management
Dassault Systemes Americas
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.